- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
Incyte Biosciences United Kingdom and Ireland Appoints Peter Williams As General Manager
Peter Williams
Incyte announces the appointment of Peter Williams as General Manager for Incyte Biosciences United Kingdom and Ireland. In his role, Peter will be responsible for the development of medical, regulatory and commercial strategy for Incyte’s portfolio of products in the UK and Ireland.
“On behalf of our leadership team, I would like to welcome Peter to Incyte. His extensive commercial experience will greatly enhance the teams in the UK & Ireland and support our continued growth,” said Jonathan Dickinson, Executive Vice President and General Manager for Incyte Europe.
IMF Chief Medical Officer Discusses Global Initiatives to Improve Myeloma Treatment
August 20th 2024In an interview with Pharm Exec Associate Editor Don Tracy, Joseph Mikhael, chief medical officer, IMF, offers a glimpse at multiple initiatives that the IMF is working towards to improve myeloma treatment globally.
